US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

165.73

+2.351.44%

Pre-market: 165.830.1000+0.06%08:03 EDT

Volume:10.02M

Turnover:1.66B

Market Cap:11.52B

PE:9.09

High:167.91

Open:164.60

Low:163.74

Close:163.38

52wk High:169.68

52wk Low:88.60

Shares:69.53M

Float Shares:69.53M

Volume Ratio:1.04

T/O Rate:14.41%

Dividend:0.56

Dividend Rate:0.34%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Major Insider Buying Spree Signals Big Confidence in This Biotech Stock

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)

Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus

Simply Wall St.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: P3 Health Partners (PIII) and Kailera Therapeutics, Inc. (KLRA)

Vital Infrastructure REIT Cuts Leverage as It Repositions Toward North American Healthcare Assets

Analysts’ Top Healthcare Picks: Cardinal Health (CAH), Atea Pharmaceuticals (AVIR)

Vital Healthcare Property Trust Fiscal 2026 AFFO, Net Property Income Up

MT Newswires Live

Vital Healthcare Property Trust details internalisation and capital raising in 2026 annual report

Vital Healthcare Property Trust Declares FY26 Q4 Distribution and Confirms Discounted DRP

Health Care up on Growth Hopes - Health Care Roundup

American Healthcare REIT completes stock offering for expansion

U.S. Healthcare Payer Stocks Linked To Medicare Spending Pressure

Simply Wall St.

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live

Legend Biotech Shares Fall After Oppenheimer Downgrade

MT Newswires Live

HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program

Acadia Healthcare (ACHC) Securities Lawsuit Moves Forward After Court Denies Dismissal Bid

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says

MT Newswires Live

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/XBI/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":165.73,"timestamp":1787342400000,"preClose":163.38,"halted":0,"volume":10016422,"hourTrading":{"tag":"盘前","latestPrice":165.83,"preClose":165.73,"latestTime":"08:03 EDT","volume":2087,"amount":346121.72898,"timestamp":1787572990466,"change":0.1,"changeRate":0.000603,"amplitude":0.006147},"delay":0,"changeRate":0.014383645489043912,"floatShares":69525000,"shares":69525000,"eps":18.23,"marketStatus":"Pre-Mkt","change":2.35,"latestTime":"08-24 08:07:40 EDT","open":164.6,"high":167.9112,"low":163.74,"amount":1663136725.302,"amplitude":0.025531,"askPrice":165.83,"askSize":147,"bidPrice":165.6,"bidSize":4,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":165.73,"sharesOutstanding":63325000,"nav":165.682052,"aum":11336794406.12,"dividendRate":0.0034,"bidAskSpread":0.000298,"preHourTrading":{"tag":"盘前","latestPrice":165.83,"preClose":165.73,"latestTime":"08:03 EDT","volume":2087,"amount":346121.72898,"timestamp":1787572990466,"change":0.1,"changeRate":0.000603,"amplitude":0.006147},"postHourTrading":{"tag":"盘后","latestPrice":166.35,"preClose":165.73,"latestTime":"19:59 EDT","volume":85473,"amount":14172263.124,"timestamp":1787356794970,"change":0.62,"changeRate":0.003741,"amplitude":0.005008},"volumeRatio":1.0362914545448074,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"157.0","timestamp":1787329639281,"price":2.21,"volume":1350,"amount":298350,"type":"-"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"150.0","timestamp":1787329639281,"price":0.99,"volume":1350,"amount":133650,"type":"+"}]},"impliedVol":0.3255,"impliedVolPercentile":0.732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":69525000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0362914545448074,"shares":69525000,"dividePrice":0.5635,"high":167.9112,"amplitude":0.025531,"preClose":163.38,"low":163.74,"week52Low":88.6,"pbRate":"--","week52High":169.68,"institutionHeld":0.8511,"latestPrice":165.73,"committee":-0.94702,"eps":18.23,"divideRate":0.0034,"volume":10016422,"delay":0,"ttmEps":18.23,"open":164.6,"prevYearClose":121.93,"prevWeekClose":165.73,"prevMonthClose":147.01,"prevQuarterClose":158.25,"fiveDayClose":157.41,"twentyDayClose":150.48,"sixtyDayClose":134.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659018265","title":"Major Insider Buying Spree Signals Big Confidence in This Biotech Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659018265","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659018265?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:02","pubTimestamp":1786586574,"startTime":"0","endTime":"0","summary":"New insider activity at BlossomHill Therapeutics, Inc. ( ($BLSM) ) has taken place on August 12, 2026. BlossomHill Therapeutics, Inc. has attracted...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-buying-spree-signals-big-confidence-in-this-biotech-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-buying-spree-signals-big-confidence-in-this-biotech-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","SHAP.U","BK4588","BK4585","BLSM","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659184011","title":"Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659184011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659184011?lang=en_us&edition=fundamental","pubTime":"2026-08-13 09:30","pubTimestamp":1786584613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-owlet-owlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-owlet-owlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4082","ANRO","XBI","BK4137","BK4588","OWLT","LU0029874061.USD","HCSG","BK4585","LABU","LU0128526141.USD","XLV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918429","title":"Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918429","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918429?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:37","pubTimestamp":1786581477,"startTime":"0","endTime":"0","summary":"Krystal Biotech earnings and revenue momentum come into focus\nKrystal Biotech (KRYS) is back in the spotlight after reporting second quarter 2026 results that included net income of US$54.77 million and basic earnings per share from continuing operations of US$1.85.\nSee our latest analysis for Krystal Biotech.\nThe recent earnings update and 24% net product revenue growth for VYJUVEK came after a strong run, with Krystal Biotech posting a year to date share price return of 34.81% and a 1 year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-earnings-and-pipeline-progress-put-valu","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-earnings-and-pipeline-progress-put-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KRYS","XBI","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659818171","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: P3 Health Partners (PIII) and Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659818171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659818171?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:10","pubTimestamp":1786579809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on P3 Health Partners (PIII) and Kailera Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-p3-health-partners-piii-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-p3-health-partners-piii-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIII","LU0029874061.USD","BK4585","BK4139","BK4196","LU0128526141.USD","BK4588","BK4581","KLRA","OZEM","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659189378","title":"Vital Infrastructure REIT Cuts Leverage as It Repositions Toward North American Healthcare Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2659189378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659189378?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:32","pubTimestamp":1786577575,"startTime":"0","endTime":"0","summary":"NorthWest Healthcare Properties REIT ( ($TSE:VITL.UN) ) has shared an announcement. Vital Infrastructure Property Trust reported second-quarter 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-infrastructure-reit-cuts-leverage-as-it-repositions-toward-north-american-healthcare-assets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-infrastructure-reit-cuts-leverage-as-it-repositions-toward-north-american-healthcare-assets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","RJMG","LU0029874061.USD","LU0128526141.USD","BK4107","YLDW","LABU","AFG","RNTY","PSCF","BK4581","BK4585","MDIV","REIT","BK4117","HCSG","DFRA","IQRA","BK4588","IVRA","XLV","REIX","BK4137","BPRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659518937","title":"Analysts’ Top Healthcare Picks: Cardinal Health (CAH), Atea Pharmaceuticals (AVIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659518937","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659518937?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:30","pubTimestamp":1786577410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH) and Atea Pharmaceuticals (AVIR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cardinal-health-cah-atea-pharmaceuticals-avir-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cardinal-health-cah-atea-pharmaceuticals-avir-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0154236417.USD","LU0006061336.USD","BK4137","BK4581","LU1880398471.USD","BK4175","LABU","LU0162691827.USD","AVIR","LU0029874061.USD","LU0310800965.SGD","BK4588","LU0128526141.USD","LU1983299246.USD","HCSG","LU0792757196.USD","SG9999001440.SGD","XBI","LU1880398554.USD","LU1267930490.SGD","LU1571399168.USD","LU0211328371.USD","LU0128525689.USD","LU0310799852.SGD","XLV","LU0211327993.USD","LU1267930813.SGD","CAH","BK4007","LU0889566641.SGD","LU0072461881.USD","LU0052756011.USD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659185823","title":"Vital Healthcare Property Trust Fiscal 2026 AFFO, Net Property Income Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185823","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185823?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:34","pubTimestamp":1786570476,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property Trust  logged NZ$0.115 in adjusted funds from operations  per unit for the fiscal 2026, compared with NZ$0.1041 a year ago, a Thursday filing showed.For the 12 months ended June 30, net property income was NZ$162.2 million versus NZ$148.8 million previously, the New Zealand-listed real estate investment trust added.The board declared a quarterly dividend of NZ$0.024375 per unit, unchanged from the prior corresponding period, payable Sept. 3 to shareholders on record as of Aug. 20.The company expects fiscal 2027 distributions of NZ$0.0975 per unit, payable quarterly.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4588","VHP.NZ","XBI","BK8059","CLR.SI","XLV","BK8073","GLS.SI","SRU.SI","JJJ.SI","LABU","CFA.SI","SRT.SI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918552","title":"Vital Healthcare Property Trust details internalisation and capital raising in 2026 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918552?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:22","pubTimestamp":1786569753,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) has shared an update. Vital Healthcare Property Trust has lodged its FMCA-compliant 2026 annual report with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-details-internalisation-and-capital-raising-in-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-details-internalisation-and-capital-raising-in-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK8059","BK4581","XLV","BK4585","BK8073","PSIL","XBI","VHP.NZ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659855221","title":"Vital Healthcare Property Trust Declares FY26 Q4 Distribution and Confirms Discounted DRP","url":"https://stock-news.laohu8.com/highlight/detail?id=2659855221","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659855221?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:22","pubTimestamp":1786569743,"startTime":"0","endTime":"0","summary":"An update from Vital Healthcare Property ( ($NZ:VHP) ) is now available. Vital Healthcare Property Trust has declared a fourth-quarter FY26 distrib...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-declares-fy26-q4-distribution-and-confirms-discounted-drp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-declares-fy26-q4-distribution-and-confirms-discounted-drp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4585","BK4581","VHP.NZ","BK8073","BK8059","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659418347","title":"Health Care up on Growth Hopes - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659418347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659418347?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:21","pubTimestamp":1786569660,"startTime":"0","endTime":"0","summary":"Health-care companies rose amid optimism about the growth outlook in the sector.Eli Lilly shares rose after it sued several U.S. entities, including a California spa and online sellers of experimental peptides, alleging they were selling unlicensed versions of one of its obesity drugs.Shares of Canadian drug maker Apotex Health fell after it swung to a quarterly loss on lower revenue. The company said Canadian launches of generic Ozempic and Wegovy obesity drugs helped to offset an expiring cancer-drug license.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","XLV","LABU","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183318","title":"American Healthcare REIT completes stock offering for expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183318","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183318?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:54","pubTimestamp":1786568067,"startTime":"0","endTime":"0","summary":"American Healthcare REIT, Inc. ( ($AHR) ) has provided an announcement. On August 12, 2026, American Healthcare REIT closed a public offering of 13...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-completes-stock-offering-for-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-completes-stock-offering-for-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YLDW","RJMG","BK4585","BK4225","BK4581","DFRA","LABU","IVRA","IQRA","BK4588","REIT","MDIV","XBI","AHR","PSCF","XLV","BPRE","REIX","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659818301","title":"U.S. Healthcare Payer Stocks Linked To Medicare Spending Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2659818301","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659818301?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:34","pubTimestamp":1786566849,"startTime":"0","endTime":"0","summary":"With the U.S. deficit swelling, Medicare spending in sharper focus and a $39.9b debt pile driving interest costs higher, investors are seeing how government budgets can ripple through markets in real time. That stress can unsettle broad indices yet create pockets of potential in Medicare exposed insurers. In this context, this article walks through 3 U.S. healthcare payer stocks tied to these trends and explains why they might matter for your watchlist.\nThe stocks covered below are just a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ardt/ardent-health/news/us-healthcare-payer-stocks-linked-to-medicare-spending-press","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ardt/ardent-health/news/us-healthcare-payer-stocks-linked-to-medicare-spending-press","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","XLV","AIPO","LABU","BK4588","BK4185","BK4581","XBI","BK4082","BK4585","INNV","LNGR","LU0029874061.USD","ARDT","TCMD","BK4137","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907385","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907385?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:58","pubTimestamp":1786564721,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Merck  shares rose 2.4% after Daiwa upgraded the stock to outperform from neutral and raised its price target to $143 per share from $120.Cencora  said that certain Walgreens volume that was being serviced by the company, separate from the prime vendor agreement, has started moving outside the company from July 1. Meanwhile, Cencora said its prime vendor agreement remains unchanged and accounts for the majority of its business with Walgreens. Cencora shares fell past 5%.Legend Biotech  could see pressures from competition and recent leadership change, potentially weighing on Carvykti myeloma therapy strategy, Oppenheimer said. It downgraded Legend to perform from outperform. Shares fell 5.2%.Definium Therapeutics  shares rose 5% after the firm said its phase 3 trial","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEMS","LU1093756168.USD","BK4139","LU1934455194.USD","SG9999004303.SGD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","BK4175","LU2089984988.USD","LU0006306889.USD","SG9999001440.SGD","LU0130102774.USD","LU1093756325.SGD","LU1057294990.SGD","DFTX","FHLC","LU0861579265.USD","LU2125909247.SGD","LU0965508806.USD","LU1116320737.USD","LABU","LU2361044865.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU2023250843.SGD","LU1974910355.USD","LU0942090050.USD","LU0965509010.AUD","LU2491050071.SGD","LU0266013472.USD","BK4581","LU0203347892.USD","LU0211331839.USD","LU0648001328.SGD","LU2360032135.SGD","LU0106261372.USD","LU1929549753.HKD","IE0002141913.USD","BK4516","LU0265550946.USD","LU1035773651.USD","BK4588","SG9999014567.USD","LU1941712264.USD","LU0477156953.USD","LU1585245621.USD","LU1061106388.HKD","BK4533","GDOC","TRUH","BK4550","PPH","IE00BJJMRZ35.SGD","LU0238689110.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU1989771016.USD","LU1119994496.HKD","LU2468319806.SGD","LU1917777945.USD","LU1066051498.USD","LU1162221912.USD","LU0868494708.USD","SG9999013999.USD","LU1989772923.USD","LU2361044949.HKD","PAWZ","LU0859254822.USD","IE00B2B36J28.USD","BK4534","SG9999002232.USD","LU2106854487.HKD","LU1989772840.SGD","BK4585","BMED","LU2461242641.AUD","IHE","LU0208291251.USD","CANC","LU0234572021.USD","LU0122379950.USD","SGXZ23171101.USD","LU2125909593.SGD","LU1201861249.SGD","IE0009355771.USD","LU1023059063.AUD","LU2361045086.USD","LU1934455277.USD","LU0098860793.USD","RXL","IE00BSNM7G36.USD","LU0320765646.SGD","XLV","SG9999014575.USD","LEGN","LU1069347547.HKD","LU2112291526.USD","LU2491049909.HKD","LU1571399168.USD","LU0289739699.SGD","IXJ","LU2237957902.USD","LU1941712348.USD","BK4084","LU0965509283.SGD","XBI","LU0868494617.USD","LU0265550359.USD","LU0985320562.USD","JDOC","FTXH","LU1037948897.HKD","HRTS","LU1430594728.SGD","SG9999015341.SGD","LU0124676726.USD","BK4007","LU0058720904.USD","LU0070302665.USD","LU0130517989.USD","LU1923622614.USD","LU0965509101.SGD","LU2125154935.USD","LU2237957811.SGD","SG9999015358.SGD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","COR","LU1291159041.SGD","LU2491050154.USD","BK4529","SG9999001176.USD","LU1934455863.HKD","LU0203345920.USD","LU2324357040.USD","LU2023250504.SGD","LU1699723380.USD","BK4505","LU1983299246.USD","LU1116320901.HKD","LU1814569148.SGD","IE00BBT3K403.USD","LU2433249047.HKD","LU1084165304.USD","LU2125154778.USD","MEDI","LU0689626769.HKD","SG9999001176.SGD","LU0320765489.SGD","VHT","LU1066051225.USD","BK4559","IYH","IBB","LU1066051811.HKD","LU2357627491.SGD","MRK","IE00BN8TJ469.HKD","LU0823416689.USD","SG9999014542.SGD","LU0432979614.USD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659053904","title":"Legend Biotech Shares Fall After Oppenheimer Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2659053904","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659053904?lang=en_us&edition=fundamental","pubTime":"2026-08-13 02:20","pubTimestamp":1786558851,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) shares were down 5.6% in Wednesday trading after Oppenheimer downgraded the company's stock to perform from outperform.Trading volume stood at about 2 million shares, compared with a daily average of roughly 2.7 million.Price: 20.59, Change: -1.24, Percent Change: -5.68","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","LEGN","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659041419","title":"HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659041419","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659041419?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:55","pubTimestamp":1786557343,"startTime":"0","endTime":"0","summary":"Theriva Biologics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group maintai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","TOVX","LABU","BK4588","BK4585","XBI","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659356904","title":"Acadia Healthcare (ACHC) Securities Lawsuit Moves Forward After Court Denies Dismissal Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2659356904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659356904?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:30","pubTimestamp":1786555844,"startTime":"0","endTime":"0","summary":"Acadia Healthcare Company, Inc. (ACHC) will continue facing a federal securities lawsuit after a Tennessee federal judge denied the defendants’ mot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/acadia-healthcare-achc-securities-lawsuit-moves-forward-after-court-denies-dismissal-bid?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/acadia-healthcare-achc-securities-lawsuit-moves-forward-after-court-denies-dismissal-bid?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","ACHC","XLV","BK4185","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901648","title":"Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901648?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:00","pubTimestamp":1786554032,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NextCure (NXTC) and CalciMedica (CALC). NextCure (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CALC","BK4581","XLV","BK4137","BK4585","LU0029874061.USD","BK4139","HCSG","BK4007","XBI","NXTC","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901615","title":"Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901615?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:50","pubTimestamp":1786553410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4575","XBI","BK4121","BK4588","LABU","LU0029874061.USD","LU0128526141.USD","BK4007","XLV","BK4137","BK4581","BNGO","BK4585","PYPD","LQDA","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658909519","title":"Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658909519","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658909519?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:58","pubTimestamp":1786550316,"startTime":"0","endTime":"0","summary":"Legend Biotech  could see pressures from competition and its recent leadership change, potentially weighing on its Carvykti myeloma therapy strategy, Oppenheimer said in a Wednesday note.Chief Executive Ying Huang resigned from the company in July and his departure raised concerns over strategies as Anito-cel nears potential approval and commercialization as a competing myeloma treatment, the investment firm said.Anito-cel's approval could pressure Legend Biotech's stock and Carvykti's near-term growth, but Oppenheimer noted that it continues to expect Carvykti to corner a majority of the market share in multiple myeloma.Carvykti sales could still peak at about $5 billion, but its near-term position could depend on the new CEO's strategic vision, the brokerage said.Oppenheimer downgraded Legend Biotech to perform from outperform and adjusted the price target to $40 from $75.Price: 20.66, Change: -1.17, Percent Change: -5.36","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEMS","BK4588","BK4505","BK4127","LEGN","CANC","OPY","MEDI","BK4581","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658690574","title":"Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658690574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658690574?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:01","pubTimestamp":1786546891,"startTime":"0","endTime":"0","summary":"Legend Biotech  is positioned to sustain profitability after achieving adjusted net income profitability in Q2 and given its existing cash runway, RBC Capital Markets said.Revenue increased to $387.5 million from $255.1 million. Revenue growth was mainly driven by myeloma therapy Carvykti, according to the note Tuesday.Carvykti's market share as an earlier-line treatment for myeloma continues to grow. RBC said the 2nd-to-4th-line market remains underpenetrated by BCMA-targeting therapies.The investment firm believes near-term risk to Carvykti, developed in collaboration with Johnson & Johnson , from bispecifics and future CAR-T entrants is being overstated. The continued investment by Legend and J&J supports the drug's growth outlook, according to the note.Johnson & Johnson has reiterated Carvykti's potential to generate more than $5 billion in annual sales.RBC has an outperform rating on the stock and lowered its price target to $58 from $59.Shares of Legend Biotech were down 3.4% in ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","CANC","IXJ","LU0943347566.SGD","LU1145028129.USD","LU2133065610.SGD","IHE","TRUH","LU2487616109.SGD","JDOC","FHLC","BK4533","XBI","SGXZ57979304.SGD","LU0787776722.HKD","LU1074936037.SGD","IE00BKVL7J92.USD","LU0098860793.USD","LU0124676726.USD","XLV","LEGN","LU0072461881.USD","LU0683600562.USD","LU1066053197.SGD","IE00BFTCPJ56.SGD","MEDX","LU1066051811.HKD","LU2505996681.GBP","RXL","IE000WAW04H5.SGD","LU1244550577.SGD","MEDI","LU1196500208.SGD","BK4532","LU2602419157.SGD","VHT","LU1989771016.USD","PJP","BK4585","BK4588","LU0689472784.USD","IE00BSNM7G36.USD","BMED","GDOC","JNJ","MEMS","IYH","LU0795875169.SGD","LU0640476718.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":15,"totalSize":383,"code":"91000000","status":"200"}]}}